Tracking the impact of vaccines on children's respiratory and stomach viruses.
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
This study is looking at how well vaccines work to protect kids from stomach and respiratory viruses by tracking children who come to Children's Mercy Hospital with these illnesses, so we can better understand how these viruses affect young ones.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Mercy Hosp (Kansas City, Mo) NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-11046484 on NIH RePORTER |
What this research studies
This research focuses on monitoring and assessing the effectiveness of vaccines in preventing enteric and respiratory viruses in children. It involves active surveillance of children who visit the Children's Mercy Hospital in Kansas City for acute gastroenteritis and respiratory illnesses. The study will collect data through interviews with parents, electronic medical records, and laboratory tests on stool and respiratory specimens to identify various pathogens. By expanding the surveillance network, the research aims to provide valuable insights into the burden and natural history of these illnesses in the pediatric population.
Who could benefit from this research
Good fit: Ideal candidates for participation are children seeking care for acute gastroenteritis or respiratory illnesses at Children's Mercy Hospital.
Not a fit: Patients who are not children or those not seeking care for the specified illnesses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccine strategies that better protect children from serious viral infections.
How similar studies have performed: Previous research has shown success in similar surveillance approaches for monitoring vaccine effectiveness and disease burden in pediatric populations.
Where this research is happening
Kansas City, United States
- Children's Mercy Hosp (Kansas City, Mo) — Kansas City, United States (Active)
Researchers
- Principal investigator: Selvarangan, Rangaraj — Children's Mercy Hosp (Kansas City, Mo)
- Study coordinator: Selvarangan, Rangaraj
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.